C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
Clinical trial NCT04107740 · COMPLETED
Trial details
- NCT number
- NCT04107740
- Sponsor
- HLB Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-04
- Primary completion
- 2021-02-08
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.